Neutralization of the SARS-CoV-2 Omicron BA.1 and BA.2 Variants

  • Yu J
  • Collier A
  • Rowe M
  • et al.
256Citations
Citations of this article
185Readers
Mendeley users who have this article in their library.
Get full text

Abstract

The SARS-CoV-2 Omicron variant (B.1.1.529) has three major lineages BA.1, BA.2, and BA.3 1 . BA.1 rapidly became dominant and has demonstrated substantial escape from neutralizing antibodies (NAbs) induced by vaccination 2-4 . BA.2 has recently increased in frequency in multiple regions of the world, suggesting that BA.2 has a selective advantage over BA.1. BA.1 and BA.2 share multiple common mutations, but both also have unique mutations 1 ( Fig. 1A ). The ability of BA.2 to evade NAbs induced by vaccination or infection has not yet been reported. We evaluated WA1/2020, Omicron BA.1, and BA.2 NAbs in 24 individuals who were vaccinated and boosted with the mRNA BNT162b2 vaccine 5 and in 8 individuals who were infected with SARS-CoV-2 ( Table S1 ).

Cite

CITATION STYLE

APA

Yu, J., Collier, A. Y., Rowe, M., Mardas, F., Ventura, J. D., Wan, H., … Barouch, D. H. (2022). Neutralization of the SARS-CoV-2 Omicron BA.1 and BA.2 Variants. New England Journal of Medicine, 386(16), 1579–1580. https://doi.org/10.1056/nejmc2201849

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free